|
Anlon Healthcare Acquires Bizotic Lifescience Limited09 Dec 2025
Overview of the Acquisition Deal Anlon Healthcare Limited has announced its strategic decision to acquire Bizotic Lifescience Private Limited, marking... Continue Reading
|
|
Europe’s Pharmaceutical Future Innovation Under Pressure08 Dec 2025
After more than three decades in the pharmaceutical industry, one fundamental truth emerges: science transforms lives, but policy determines whether... Continue Reading
|
|
Supriya Lifescience Stock Technical Analysis Guide08 Dec 2025
Current Market Position and Price Dynamics Supriya Lifescience currently trades at ₹755.60, representing a positive movement from its previous closing... Continue Reading
|
|
Eiko Lifesciences Financial Performance Analysis 202505 Dec 2025
Quarterly Financial Strength Record-Breaking Q2 FY2025-26 Results Eiko Lifesciences delivered an exceptional performance in the second quarter of fiscal year... Continue Reading
|
|
Nectar Lifesciences Shares Surge on Buyback News05 Dec 2025
Market Performance Overview Nectar Lifesciences shares witnessed remarkable momentum on the Bombay Stock Exchange (BSE), surging 17.5 per cent and... Continue Reading
|
|
Scotland’s Life Sciences Strategy Targets £25bn04 Dec 2025
Introduction to Scotland’s Life Sciences Vision Scotland has unveiled an ambitious refreshed Life Sciences Strategy in November 2025, marking a... Continue Reading
|
|
Investment Guide Buy Sell Hold Five Stocks04 Dec 2025
Introduction to Stock Investment Decisions Navigating the stock market requires careful analysis and strategic decision-making. For investors evaluating their portfolio,... Continue Reading
|
|
|
SUPRIYA Lifescience Strategic Growth Through Advanced Manufacturing03 Dec 2025
Facility Overview and Infrastructure SUPRIYA Lifescience Ltd continues to strengthen its position in the pharmaceutical manufacturing sector through strategic investments... Continue Reading
|
|
|
Supriya Lifescience Stock Analysis and Outlook03 Dec 2025
Current Price Movement and Technical Trends Supriya Lifescience shares closed at ₹744.60 in the most recent trading session, marking a... Continue Reading
|
|
Dong Kook Lifescience Signs Strategic China Deal02 Dec 2025
Strategic Partnership Overview Dong Kook Lifescience announced on December 1st that it has signed a memorandum of understanding (MOU) establishing... Continue Reading
|












